These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34854578)

  • 21. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
    Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
    J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Key Role of Phosphate on Vascular Calcification.
    Cozzolino M; Ciceri P; Galassi A; Mangano M; Carugo S; Capelli I; Cianciolo G
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30970562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the mechanisms of vascular calcification in chronic kidney disease.
    Wang Z; Gui Z; Zhang L; Wang Z
    J Cell Physiol; 2024 Oct; ():e31464. PubMed ID: 39392232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
    Xu TH; Sheng Z; Li Y; Qiu X; Tian B; Yao L
    Life Sci; 2020 Nov; 261():118121. PubMed ID: 32693242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted Frizzled-Related Protein 5 Ameliorates Vascular Calcification in a Rat Model of Chronic Kidney Disease through the Wnt/β-Catenin Pathway.
    Deng D; Han X; Diao Z; Liu W
    Kidney Blood Press Res; 2021; 46(6):758-767. PubMed ID: 34469882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant associations between bone mineral density and vascular calcification in patients with different stages of chronic kidney disease.
    Uhlinova J; Kuudeberg A; Metsküla K; Lember M; Rosenberg M
    BMC Nephrol; 2022 Oct; 23(1):327. PubMed ID: 36199013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling.
    Ning FL; Tao J; Li DD; Tian LL; Wang ML; Reilly S; Liu C; Cai H; Xin H; Zhang XM
    Acta Pharmacol Sin; 2022 Mar; 43(3):624-633. PubMed ID: 34163023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of incident chronic kidney disease related-mineral bone disorders in chronic kidney disease Stage 4 and 5: A hospital based cross-sectional survey.
    Valson AT; Sundaram M; David VG; Deborah MN; Varughese S; Basu G; Mohapatra A; Alexander S; Jose J; Roshan J; Simon B; Rebekah G; Tamilarasi V; Jacob CK
    Indian J Nephrol; 2014 Mar; 24(2):97-107. PubMed ID: 24701042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory effects of nutritional and metabolic disorders on vascular calcification in chronic kidney disease: a narrative review.
    Xiong Y; Yu Y; Su B
    Ann Transl Med; 2023 Oct; 11(11):384. PubMed ID: 37970595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease.
    Disthabanchong S; Boongird S
    World J Nephrol; 2017 May; 6(3):100-110. PubMed ID: 28540199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
    Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
    BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular calcification in chronic kidney disease.
    Covic A; Kanbay M; Voroneanu L; Turgut F; Serban DN; Serban IL; Goldsmith DJ
    Clin Sci (Lond); 2010 Apr; 119(3):111-21. PubMed ID: 20443781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review.
    Wu PY; Lee SY; Chang KV; Chao CT; Huang JW
    Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Mitochondrial Dysfunction in CKD-Related Vascular Calcification: From Mechanisms to Therapeutics.
    Huang J; Hao J; Wang P; Xu Y
    Kidney Int Rep; 2024 Sep; 9(9):2596-2607. PubMed ID: 39291213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
    Hruska KA; Mathew S; Davies MR; Lund RJ
    Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular calcification score on plain radiographs of the feet as a predictor of peripheral arterial disease in patients with chronic kidney disease.
    An WS; Son YK; Kim SE; Kim KH; Yoon SK; Bae HR; Rha SH
    Int Urol Nephrol; 2010 Sep; 42(3):773-80. PubMed ID: 20041296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances in the Management of Vascular Calcification in Patients with End-Stage Renal Disease.
    Nitta K; Ogawa T; Hanafusa N; Tsuchiya K
    Contrib Nephrol; 2019; 198():62-72. PubMed ID: 30991406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
    Dong QQ; Tu YC; Gao P; Liao QQ; Zhou P; Zhang H; Shu HP; Sun LL; Feng L; Yao LJ
    Theranostics; 2024; 14(2):861-878. PubMed ID: 38169564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.